Paediatric antidepressants: Benefits and risks
Author:
Affiliation:
1. Department of Psychiatry, Hergest Unit, Bangor, Wales, UK
2. Department of Psychiatry, Bangor, Wales, UK
3. Robinson Research Institute, University of Adelaide, SA, Australia
Publisher
IOS Press
Subject
Public Health, Environmental and Occupational Health,Health Policy,General Medicine
Reference21 articles.
1. Paroxetine v clomipramine in adolescents with severe major depression;Braconnier;Journal of American Academy of Child and Adolescent Psychopharmacology,2006
2. A double-blind, randomized placebo controlled trial of fluoxetine in depressed children and adolescents;Emslie;Archives of General Psychiatry,1997
3. Fluoxetine for acute treatment in children and adolescents: A placebo-controlled randomized clinical trial;Emslie;J Am Acad Child Adoles Psychiatry,2002
4. Escitalopram in the treatment of adolescent depression: A randomized placebo-controlled multisite trial;Emslie;J Am Acad Child Adolesc Psychiatry,2009
5. Sudden Cardiac Death and the Reverse Dodo Verdict;Healy;International J Risk & Safety in Medicine,2014
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. O USO DE ANTIDEPRESSIVOS EM CRIANÇAS E ADOLESCENTES;Revista Saúde Dos Vales;2023-11-01
2. Re: “A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder” by Strawn et al.—Concerning Harm–Benefit Ratio in a Recent Trial About Escitalopram for Generalized Anxiety Disorder;Journal of Child and Adolescent Psychopharmacology;2023-09-01
3. Latest updates on the serotonergic system in depression and anxiety;Frontiers in Synaptic Neuroscience;2023-05-09
4. Utilización de antidepresivos y prescripción fuera de ficha técnica en atención primaria en España (2013-2018);Anales de Pediatría;2022-10
5. Profil de délivrance des antidépresseurs chez l’enfant et l’adolescent en Midi-Pyrénées entre 2015 et 2017;Revue d'Épidémiologie et de Santé Publique;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3